Originally published In Press as doi:10.1074/jbc.M207402200 on August 24, 2002
J. Biol. Chem., Vol. 277, Issue 44, 41857-41864, November 1, 2002
Crystal Structure of the 47-kDa Lipoprotein of Treponema
pallidum Reveals a Novel Penicillin-binding Protein*
Ranjit K.
Deka
,
Mischa
Machius§,
Michael V.
Norgard
¶, and
Diana R.
Tomchick§
From the Departments of
Microbiology and
§ Biochemistry, University of Texas Southwestern Medical
Center, Dallas, Texas 75390
Received for publication, July 23, 2002, and in revised form, August 7, 2002
 |
ABSTRACT |
Syphilis is a complex sexually transmitted
disease caused by the spirochetal bacterium Treponema
pallidum. T. pallidum has remained exquisitely
sensitive to penicillin, but the mode of action and lethal targets for
-lactams are still unknown. We previously identified the T. pallidum 47-kDa lipoprotein (Tp47) as a penicillin-binding
protein (PBP). Tp47 contains three hypothetical consensus motifs (SVTK,
TEN, and KTG) that typically form the active center of other PBPs. Yet,
in this study, mutations of key amino acids within these motifs failed
to abolish the penicillin binding activity of Tp47. The crystal
structure of Tp47 at a resolution of 1.95 Å revealed a fold different
from any other known PBP; Tp47 is predominantly
-sheet, in contrast
to the
/
-fold common to other PBPs. It comprises four distinct
domains: two complex
-sheet-containing N-terminal domains and two
C-terminal domains that adopt immunoglobulin-like folds. The three
hypothetical PBP signature motifs do not come together to form a
typical PBP active site. Furthermore, Tp47 is unusual in that it
displays
-lactamase activity (kcat for
penicillin = 271 ± 6 s
1), a feature that
hindered attempts to identify the active site in Tp47 by
co-crystallization and mass spectrometric techniques. Taken together,
Tp47 does not fit the classical structural and mechanistic paradigms
for PBPs, and thus Tp47 appears to represent a new class of
PBP.
 |
INTRODUCTION |
Syphilis is a chronic, complex sexually transmitted disease of
humans caused by the spirochetal bacterium Treponema
pallidum. Humans are the only known reservoir for T. pallidum, and although syphilis is one of the oldest recognized
sexually transmitted diseases, a major impediment to research on
T. pallidum continues to be the inability to cultivate the
organism in vitro. Consequently, despite decades of
intensive efforts, many features of T. pallidum ultrastructure, physiology, and membrane biology remain obscure (1).
T. pallidum is exquisitely sensitive to penicillin, which
continues to be the drug of choice for syphilotherapy. Penicillin and
other
-lactams are bactericidal via their ability to inhibit cytoplasmic membrane-bound enzymes (penicillin-binding proteins (PBPs))1 involved in
peptidoglycan biosynthesis (2). Generally, bacteria contain
several PBPs that are classified within two categories (high molecular
weight or low molecular weight) (3, 4). In Escherichia coli,
the high molecular weight PBPs tend to be bifunctional
(transglycosylase/transpeptidase activities) and are the lethal targets
of
-lactams (5). The low molecular weight PBPs can be either
monofunctional DD-carboxypeptidases, bifunctional
DD-carboxypeptidases/DD-endopeptidases, or monofunctional DD-endopeptidase (6). In T. pallidum, the lethal targets for
-lactams are not known. However, two previous studies in which T. pallidum was incubated in vitro with
radiolabeled
-lactams implicated polypeptides of 94, 80, 63, 58, 47, and 38 kDa (7) or 180, 89, 80, 68, 61, 41, and 38 kDa (8) as PBPs. As a
follow-up to an earlier study by us (7), we have shown that the major 47-kDa membrane lipoprotein of T. pallidum (Tp47) is a PBP.
More recent genome information (9) has suggested that T. pallidum encodes at least three theoretical PBPs of molecular
masses of 71 (TP0500, PBP-1; TP0760, PBP-3) and 98 (TP0705; PBP-2) kDa, but direct biochemical evidence for these proteins as PBPs are lacking.
An additional protein putatively has been assigned as a serine-type
DD-carboxypeptidase (53-kDa, TP0800), and another as a
DD-carboxypeptidase (29-kDa, TP0221). No
-lactamases have been
predicted to be present in T. pallidum (9).
The notion that Tp47 is a PBP has been paradoxical. First, Tp47 has no
homologies with any other bacterial or eukaryotic proteins. Second,
conventional PBPs contain three conserved motifs,
SXXK, S(Y)XN, and KT(S)G, which comprise
the active site for the covalent binding of
-lactams (10-12). The
serine of the SXXK motif is important for nucleophilic
attack on the
-lactam ring. Tp47 contains three such appropriately
spaced hypothetical motifs (SVTK, TEN, KTG) (13). However, preliminary
experiments replacing Ser in the SVTK motif of Tp47 with Gly, Ala, Cys,
or Thr all yielded mutant enzymes that still bound
-lactam
comparable with wild-type Tp47 (14). Finally, lipidation of PBPs also
is uncommon (15).
The numerous incongruities surrounding Tp47 as a PBP prompted the
current biochemical and biophysical study. Specifically, it was
envisioned that precise structural information derived from x-ray
crystallography could provide strategic information to guide future
biochemical studies on the enzymatic activity of Tp47. In this study,
it was found that Tp47 has a crystal structure unique to any other
known PBP, and thus it appears to represent an entirely new class of
PBP.
 |
EXPERIMENTAL PROCEDURES |
Construction of Wild-type and Variant Tp47-Streptavidin Fusion
Proteins--
The post-translationally modified N-terminal cysteine of
native Tp47 was designated as amino acid 1 (16). To ensure production in E. coli of a nonlipidated version of Tp47, a DNA fragment
encoding amino acids 2-415 (residue 415 is the last amino acid before
the first TAG termination codon in tp47) (16) was amplified
by PCR using T. pallidum genomic DNA (17) as template. The
PCR primers were 5'-tccCCGCGGCTCGTCTCATCATGAGACGCA-3' and
5'-catgCCATGGTTACTACTGGGCCACTACCTCGCA-3'. The forward primer
contained both a tcc overhang and a SacII site (bold); the
reverse primer contained a catg overhang, a NcoI site (bold), and two contiguous stop codons (TTA, CTA). PCR amplification was performed using Vent DNA polymerase (New England Biolabs). Amplified fragments were cleaved with SacII and
NcoI and cloned directionally into SacII- and
NcoI-cleaved pASK-IBA7 vector (Sigma). This construct was
designated as wild type, and was verified by DNA sequencing and then
transformed into E. coli DH5
.
Site-directed mutagenesis of tp47 was carried out by a
PCR-based method, using two complementary mutation-harboring
oligonucleotides for each mutant and the QuikChange site-directed
mutagenesis kit (Stratagene). Five different mutant genes were
constructed; four encoded proteins with single amino acid substitutions
and one contained a double substitution. The mutant proteins expressed were designated as Tp47S100G, Tp47S100C, Tp47K287Q, Tp47C296A, and
Tp47H5S/H9S, based on the amino acid positions involved. Finally, a
fusion construct in which C-terminal residues 329-415 were deleted (corresponding to Domain D; see crystal structure Fig. 2 (Tp47
D)) also was constructed by PCR subcloning as described above, except that
the reverse primer was
5'-catgCCATGGTTACTAATCAGCAACTACGTCC-3'. All resulting mutants were sequenced to verify the specific
mutation(s) intended. Mutant tp47 genes were expressed in
E. coli, and the cognate proteins were purified as described
below for wild-type Tp47. SDS-PAGE analysis revealed that the mutants
expressed quantities of proteins comparable with wild-type Tp47,
suggesting that none of them was unstable (data not shown).
Expression and Purification of Tp47--
E. coli
DH5
containing the respective cloned tp47 gene fusion was
grown at 37 °C in LB medium containing 100 µg of ampicillin per
ml; when the A600 of the culture reached 0.6, the culture was shifted to 30 °C and expression of the
Tp47-streptavidin fusion protein was induced (via a tetA
promoter) by the addition of 200 µg/liter of anhydrotetracycline.
After 3 h, cells were harvested by centrifugation and solubilized
by B-PER II (Pierce). After centrifugation at 15,000 rpm for 20 min
(4 °C) to remove cellular debris, the supernatant was loaded onto a
StrepTactin-Sepharose column. The fusion protein was then purified
according to the Strep-tag II protein expression and purification
system manual (Sigma). The yield of purified proteins tended to be
about 25 mg/liter of bacterial culture. Purified protein was subjected to buffer exchange with buffer A (20 mM Hepes buffer, pH
7.4, 20 mM NaCl) using a PD-10 column (Amersham
Biosciences). The protein was then concentrated to about 15 mg/ml using
a Centricon YM-10 device (Amicon). Protein purity was analyzed by
SDS-PAGE (18) and by electrospray ionization-mass spectrometry
(ESI-MS). The concentration of purified protein was estimated
spectrophotometrically using a calculated extinction coefficient of
280 = 54,050 M
1
cm
1 (19).
-Lactam Binding to Tp47--
Binding of digoxigenin-labeled
ampicillin (Dig-Amp) to Tp47 was determined by a chemiluminescent
detection method (13, 20); the use of Dig-Amp circumvents problems
associated with utilizing radiometric methods for assaying
-lactam
binding (20).
-Lactam binding to Tp47 also was examined by ESI-MS;
in these experiments, a typical 100-µl reaction mixture contained 100 µg of protein, 2 mM ZnCl2, and 2 mM
-lactam (in buffer A) and was incubated at 37 °C
for various times. The reaction was terminated by the addition of 30 µl of 5% formic acid. Excess
-lactam was removed by a Microcon
YM-30 device (Amicon), and samples were recovered in 1% formic acid
for ESI-MS analysis (21). The peak heights of free and acylated Tp47
were measured from the ESI-MS spectra and the percentage of Tp47
acylation was calculated using the equation: % acylation = [acylated Tp47/(acylated Tp47 + free Tp47)] × 100 (22). In an
attempt to identify the Tp47 amino acid involved in penicillin binding,
liganded sample was digested with trypsin in 100 mM
ammonium bicarbonate (pH 7.8, 37 °C); after digestion for various
times, samples were subjected to MALDI-TOF MS (23).
Kinetic Analysis of
-Lactamase Activity--
The hydrolytic
activity of Tp47 on various
-lactams was assessed at 37 °C in
buffer A using a Shimadzu UV-1601PC UV-visible spectrophotometer
equipped with a thermostated multicell transport system. The molar
absorption coefficients used were as follows: penicillin G,

235 =
775 M
1
cm
1; ampicillin, 
235 =
820
M
1 cm
1; nitrocefin,

486 = 16,000 M
1
cm
1.
-Lactam solutions were freshly prepared in buffer
A. Initial rates were determined from the first 5-10% of the
reactions at various substrate concentrations. Km
and Vmax values were determined by fitting all
data to the Lineweaver-Burk equation using the program UV Probe (Shimadzu).
Tazobactam inhibition of the hydrolytic activity of Tp47 was performed
with penicillin as a competitor substrate in buffer A. Tazobactam at
various concentrations was preincubated with Tp47 for 5 min at 37 °C
before the addition of penicillin. Steady-state rates during the course
of penicillin hydrolysis were used to calculate the remaining activity.
The inhibition constant (Ki) was deduced from Dixon
plots using the UV Probe software.
Protein Crystallization and Data Collection--
Wild-type Tp47
described above did not yield crystals in preliminary screening
experiments. However, one of the variant versions of Tp47, in which
His-5 and His-9 were replaced with Ser (Tp47H5/H9S; Fig. 1),
crystallized readily and thus was designated as crystallizable Tp47
(cTp47). Of particular importance, cTp47 retained PBP activity comparable with the wild-type (Fig. 1). cTp47 was crystallized by the
hanging-drop vapor diffusion method (24) using 24-well Linbro plates
(Hampton Research) at room temperature. Sparse matrix crystallization
kits (Hampton Research) were used to screen preliminary crystallization
conditions. Crystals of average dimension of 50 µm appeared within
3-4 weeks. Further growth of the crystals was hindered because of
phase separation/oil formation, and these crystals diffracted poorly to
a Bragg spacing (dmin) of 6 Å. Crystallization optimization using dextran sulfate eliminated the phase separation and
yielded substantially larger crystals (about 500 µm) within 2-4 days
that diffracted to better than a dmin of 3 Å.
Crystals were routinely obtained with drops containing 5 µl of
protein solution (about 15 mg/ml in buffer A), and 5 µl of 32% (w/v)
PEG 4000 in 100 mM sodium citrate, pH 5.6, 200 mM ammonium acetate, 3% (w/v) dextran sulfate 8000 (Sigma), and ±100 µM ZnCl2, equilibrated against 500 µl of the latter solution at room temperature. Prior to
data collection, crystals were transferred sequentially for 5 min to
each of 5, 10, and 15% (v/v) glycerol-enriched reservoir solution for
cryogenic conditioning. Diffraction data were collected at 100 K using
a Rigaku RU300 rotating copper anode x-ray generator and
R-axis IV image plate detector (Molecular Structures Corp., The Woodlands, TX). The diffraction data were indexed, integrated, and
scaled in the HKL2000 program package (25).
The cTp47 crystals were found to exhibit the symmetry of space group
P3221 with unit cell dimensions of a = b = 129.1 Å, c = 151.5 Å. The
crystals contained two molecules per asymmetric unit. The crystal
structure of cTp47 was determined by single wavelength anomalous
dispersion using a xenon derivative. The xenon derivative of a cTp47
crystal was prepared by exposing a preconditioned native crystal (in
glycerol-enriched reservoir solution) in a xenon chamber (kindly
provided by Zhenming Wang) at 400 p.s.i. for 15 min at room
temperature. The chamber was then depressurized and the crystal
flash-cooled in liquid propane within 15 s. Diffraction data to a
dmin of 2.28 Å were recorded. The data were
reduced with the program package HKL2000. Xenon sites were identified
and refined to 3.0 Å within the program package CNS (version 1.0)
(26), resulting in an overall figure of merit of 0.35. The phases were
further improved by density modification in CNS including histogram
matching, solvent flipping, and phase extension to a
dmin of 2.28 Å, resulting in a final figure of
merit of 0.95 (Table I). After the
structure was solved, a synchrotron data set on a xenon-derivatized
cTp47 crystal was collected to a dmin of 1.95 Å at the Structural Biology 19-ID beamline at the Advanced Photon Source
(Argonne National Laboratory, Argonne, IL). Data collection and single
wavelength anomalous dispersion phasing statistics are provided in
Table I.
View this table:
[in this window]
[in a new window]
|
Table I
Data collection and refinement statistics
Data collection values are as defined in the program SCALEPACK (25).
Model refinement values are as defined in the program CNS (26).
|
|
Model Building and Structure Refinement--
Model building was
performed automatically (arp_warp 5.0) (27) and manually with the
program O (28). Structure refinement using the synchrotron data set was
carried out within CNS employing cycles of simulated annealing,
conjugate gradient minimization, and calculation of individual atomic
displacement parameters. An overall anisotropic atomic displacement
parameter and bulk solvent correction were used throughout the
refinement procedure. Water molecules were added where stereochemically
reasonable after the protein part of the model was complete. Inspection
of the Fobs
Fcalc
difference density map revealed a large volume of positive difference
density extending across the noncrystallographic 2-fold axis, and
located in the positively charged cleft between domains B and C of each
monomer. This density was modeled as a dextran sulfate polysaccharide
with an
1
6 linkage and two sulfate groups (on O-2 and O-3) per
glucose. The final model contains residues 7 to 34 and 44 to 414 of
molecule A, and residues 7 to 34 and 40 to 413 of molecule B, 14 residues with alternate conformations, five xenon atoms, two complete
and two partial sugar moieties of a dextran sulfate polysaccharide, and
407 water molecules. Residues 2 to 6, 35 to 43, and 415 in molecule A,
and residues 2 to 6, 35 to 39, and 414 to 415 in molecule B were
disordered in the crystal structure and could not be traced in the
electron density. The final Rfree value is
23.5% and the Rwork value is 21.2% (Table
I).
Analytical Ultracentrifugation--
Sedimentation equilibrium
studies were performed in a Beckman XL-1 Optima analytical
ultracentrifuge at 4 °C. Tp47 samples corresponding to absorbancies
of 0.1, 0.2, and 0.4 at 280 nm in buffer A were used. Samples were
centrifuged at 14,000 × g to remove aggregates prior
to loading. Experiments were conducted at a rotor speed of 13,000 and
18,000 rpm and the radial scans at 280 nm were recorded until
equilibrium was reached. The sedimentation equilibrium data were
analyzed using the supplied software.
 |
RESULTS AND DISCUSSION |
Expression and Purification of Tp47--
Bacterial lipoproteins
are membrane proteins by virtue of their three long-chain fatty acids
(post-translationally added to an N-terminal cysteine) that serve
solely as membrane insertion anchors (29). As such, the long-chain
fatty acids do not contribute to the conformation of the protein. The
proteins, in the absence of their acyl chains, thus tend to be water
soluble (consistent with the polypeptides protruding into the periplasm
or extracellular environment). A cloning strategy therefore was
implemented in which the leader sequence and N-terminal cysteine codon
of tp47 were deleted, ultimately to yield a nonlipidated,
water soluble version of Tp47. Finally, soluble Tp47 and its variants
were created as fusion proteins with an N-terminal streptavidin tag,
which is only 18 amino acids long; the streptavidin tag thus should have minimal, if any, conformational influence on Tp47. This contention was corroborated by the findings that the fusion proteins performed as
predicted in PBP assays (see below).
Properties of Mutant Tp47 Enzymes--
Ser-100 of a putative SVTK
tetrad in Tp47 (13) was altered to cysteine (Tp47S100C); this mutation
did not abolish Dig-Amp binding (Fig. 1)
or penicillin binding to Tp47 (ESI-MS data not shown). Similarly,
conversion of Ser-100 to glycine did not abrogate the binding of
penicillin to Tp47, as assessed by ESI-MS (not shown). Thus, as
initially proposed (14), it appears that Tp47 does not employ an
active-site serine to serve as a nucleophile and subsequent covalent
attachment site for
-lactams. This is in sharp contrast to what has
been observed for other classical PBPs (30, 31). That a mutation of the
presumptive active site serine had no influence on the PBP activity of
Tp47 provided the first compelling evidence that Tp47 might be
dissimilar from other conventional, serine-type PBPs.

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 1.
Binding of Dig-Amp to wild-type
(Wt) and mutant variants of Tp47. Recombinant
versions of Tp47 incubated with Dig-Amp were separated by SDS-PAGE,
electrotransferred to nylon membrane, and developed by
chemiluminescence (13, 20). Dig-Amp binding was assessed in the
presence of ZnCl2 except where noted ( ZnCl2).
DigAmp, wild-type Tp47 without Dig-Amp treatment.
|
|
The KTG triad also forms a key component of the active site cleft and
is highly conserved within PBPs (10-12). However, if Tp47 is not a
serine-type PBP, it was postulated that the KTG motif in Tp47 may be
coincidental, or may function in some other unknown manner. For
example, the positive charge on the Lys might interact with the
carboxylate group of the D-Ala-D-Ala, and hence the carboxylate group of penicillin (30, 32). However, when Lys-287 of
the KTG triad in Tp47 was mutated to Gln (Tp47K287Q), the mutant
protein retained its penicillin binding activity (Fig. 1). Inasmuch as
the mutation of Lys in the KTG motifs of other PBPs typically adversely
impacts PBP activity (30), our results further underscore the atypical
character of Tp47.
cTp47 Structure--
Findings that Tp47 seemed not to rely on
either an active site serine (of SVTK) nucleophile or a KTG motif for
PBP activity were anomalous. This prompted a structural approach to
gain further insights into the structure-function relationships for
Tp47 as perhaps a novel PBP. Initially, crystal growth of cTp47 was
hampered by the occurrence of phase separation, and the resulting
crystals were small and diffracted poorly to a Bragg spacing
(dmin) of 6 Å. Phase separation could be
overcome by the addition of dextran sulfate, resulting in larger
crystals (up to 500 µm in the largest dimension) that diffracted to a
dmin of 3 Å. These crystals exhibited the
symmetry of space group P3221, with two molecules per
asymmetric unit. The crystal structure of cTp47 was determined via the
single wavelength anomalous dispersion technique using a xenon
derivative. Derivatization with xenon not only provided phase
information, but also increased the diffraction limit of the cTp47
crystals to a dmin of 1.95 Å using synchrotron radiation.
The crystal structure of cTp47 revealed four distinct domains arranged
to give the molecule a crab-like appearance (Fig.
2). The first domain (domain A; residues
7 to 34 and 156 to 204) is mainly composed of
-strands and is
sequentially non-contiguous. The core of this domain is formed by a
strand-helix-strand motif (A
2-A
3-A
3) (Fig.
3) in a right-handed superhelical
arrangement. Adjacent to A
2 is a
-hairpin (strands A
4 and
A
5) whose tip interacts with the helix to create a barrel-like
structure. The N terminus of cTp47 forms a
-strand (A
1) that
inserts between A
2 and A
3 to complete a five-stranded, highly
twisted, mixed
-sheet (order 3, 1, 2, 4, 5). A helix-loop-helix
motif (A
1 and A
2) next to the
-hairpin completes domain A and
connects to the adjacent domain B. A structural comparison of this
domain using the program DALI (33) did not reveal any similarity with proteins in the Protein Data Bank (highest Z-score of 1.7). The largest
recognizable structural motif within this domain is generated by strand
A
1, helix A
3, and strand A
3 that forms an anti-parallel two-stranded
-sheet with an opposing helix. This motif also has been
observed in the Lactobacillus casei Hpr kinase (Protein Data Bank code 1jb1).

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 2.
Stereoview of the cTp47 monomer.
Domains A-D are drawn in different colors to highlight the domain
boundaries. The residues of the hypothetical PBP sequence motifs are
labeled I (100SVTK), II (183TEN), and
III (287KTG) (gray sticks). Figs. 2, 4, and 5
were prepared with the programs BobScript (51), POV-Ray
(www.povray.org), and GLR (L. Esser, personal
communication).
|
|

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 3.
Topology diagram of domain A
(green) and domain B (red) of
cTp47. Strands are depicted as arrows, and helices are
shown as rectangular boxes. Strands and helices are numbered
sequentially for each domain. The N and C termini of domain A are
shown.
|
|
Domain B (residues 44 to 155) contains 10
-strands and a single
-helix (Figs. 2 and 3). Its main structural feature is a central
four-stranded, anti-parallel
-sheet (strands B
1, B
10, B
2,
and B
5). This sheet is opposed by an
-helix (B
1) resulting in
an arrangement that resembles a right hand, with the strands being the
fingers (strand B
1 is the index finger) and the helix as the thumb.
The backside of the sheet forms a flat outer surface. At the N and C
termini of strand B
5 are two large
-hairpins (strands B
3/B
4
and B
8/B
9) that are oriented perpendicular to the central sheet.
These hairpins, together with large connecting loops and a third
-hairpin (strands B
5/B
6) in between them, form a second flat
outer surface. The central motif consists of strands B
1, B
10, and
B
3, and helix B
1, which is typical of cysteine proteases (34). In
fact, the topology of domain B in cTp47, except for the hairpin formed
by strands B
3 and B
4, is conserved in the cysteine protease
staphopain from Staphylococcus aureus (Protein Data Bank
code 1cv8). Yet, Tp47 does not appear to be a cysteine protease as a
cysteine is not present in a region equivalent to the active site in
cysteine proteases. Furthermore, mutation of the sole Cys (Cys-296,
which is buried in the hydrophobic core of domain C) to alanine had no
effect on PBP activity (Fig. 1), thereby ruling out involvement of this
residue in catalysis.
Domain C (residues 205 to 332) is the largest domain (Fig. 2). It is
mainly characterized by an immunoglobulin fold with two opposing
-sheets that form the typical barrel-like structure. In contrast to
the classical immunoglobulin fold, however, domain C of cTp47 has an
additional
-strand inserted after strand 3. Also, the strands are
connected by rather large loops. Helices are inserted between strands 2 and 3 and between strands 4 and 5.
Domain D (residues 333 to 414) also features an immunoglobulin
fold. In contrast to domain C, it contains only the characteristic seven-stranded barrel and short loops. As in domain C, a single
-helical turn is inserted between strands 2 and 3.
Dimer Formation--
In our crystals of cTp47, a dimer was formed
between two neighboring molecules (Fig.
4). Domains B and D act as the pincers on
a crab that make contact with the pincers of the opposing molecule. The
monomer-monomer interface has an area of about 1,830 Å2
and features a series of polar and hydrophobic interactions as well as
six ionic interactions. This finding prompted further assessment of
Tp47 dimer formation in free solution by analytical ultracentrifugation. The sedimentation equilibrium data profile produced by analytical ultracentrifugation fit well to a model comprising a single species of molecular mass of 46,178 Da (not shown),
consistent with the monomeric mass determined by SDS-PAGE and ESI-MS,
supporting the observation that Tp47 displays monomeric characters in
free solution. Consequently, Tp47 dimer formation observed within the
crystal structure could be a result of crystallization, with the high
salt concentration driving a nonspecific association of the hydrophobic
surfaces, as has been noted for other proteins undergoing crystal
packing (35, 36). In fact, when domain D (which is not required for PBP
activity) is removed from the buried surface area calculation, only
~850 Å2 surface area is buried at the monomer-monomer
interface. This is a value found at the upper limit of buried surface
area for nonspecific crystal contacts (37).

View larger version (37K):
[in this window]
[in a new window]
|
Fig. 4.
Stereoview of the cTp47 dimer. The xenon
atoms used in phasing the structure are represented as cyan
spheres. The N termini of both monomers, which occur on the same
face of the dimer, are oriented (as predicted) toward the cytoplasmic
membrane surface.
|
|
Domain Interfaces--
The first three domains in cTp47 interact
with each other through intimate domain-domain interfaces. Domain A
contacts domain B through its N-terminal segment that contains
-strand A
1 and the helix-loop-helix motif, establishing
interactions with the loop regions before the first
-strand (B
1)
and after the last
-strand (B
10) in domain B. The first linking
region between these domains (residues 34 and 44) is disordered in the
crystal structure. Domain A also interacts tightly with domain C,
involving mainly side chains in helix A
2 and the loop region between
-strands A
3 and A
4 in domain A and
-strands C
3
and
C
6 as well as the loop region between strands C
6 and C
7.
Domain B interacts with domain C via a surface that has a slightly
concave, goblet-like shape. The long loops proximal to strand B
1 and
between strands B
5 and B
6 form the sides, and helix B
1 forms
the bottom of the goblet. Residues in these regions establish a number
of polar and hydrophobic interactions with residues at the surface of
domain C, which includes strands C
3, C
3
, and C
4, the loop
region between strands C
5 and C
6, and helix C
1. Adjacent to
this interaction surface is a deep cleft located between the
-hairpin B
3/B
4 and the rest of domain B. The tip of this
hairpin, as well as the portion of this surface that is not involved in
interactions with domain C, are highly positively charged containing
five arginines, two histidines, and two lysines.
In contrast to domains A, B, and C, domain D is rather isolated. It
interacts only with domain C via an ionic interaction between Arg-330
and Glu-404 in the linker region. Consequently, the relative
disposition of domain D is expected to vary. Evidence for a larger
degree of domain motion can be found in the higher average displacement
factors for the atoms of domain D relative to the first three domains
(38.8 versus 57.8 Å2 for monomer A, 38.0 versus 67.4 Å2 for monomer B).
Comparison of Tp47 with Other PBP Structures--
The
three-dimensional structure of a conventional PBP typically is
comprised of two structural domains, one of which is predominantly
and another that is
/
(38) (Fig.
5). The active site is positioned between
these two major domains, at the edge of the central
-sheet of the
/
domain. The three signature sequence motifs of classical PBPs
that putatively were present in Tp47 do not come together in
three-dimensional space to form a typical active site. Given that Tp47
had no similarity to other known PBPs, it was hypothesized that it
might represent a new family of PBPs. Consistent with this possibility,
DALI did not identify Tp47 as a PBP, but rather had the highest
structural homology (Z-score = 6.1) to non-PBPs.

View larger version (43K):
[in this window]
[in a new window]
|
Fig. 5.
Comparison of the cTp47 structure to
representative -lactamases and PBPs.
Representative structures from the major classes of -lactamases plus
a D-Ala-D-Ala-peptidase/PBP are shown with
domains A-C of Tp47 (domain D is not required for
PBP/ -lactamase activity). Black arrows highlight the
known active sites of the representative structures. The green
sphere in the Class B structure represents a Zn2+ ion.
The Class A structure is the TEM1 -lactamase from E. coli
(Protein Data Bank code 1btl), the Class B structure is the zinc
metallolactamase from Bacillus cereus (Protein Data Bank
code 1bmc), the Class C structure is the cephalosporinase from
Enterobacter cloacae (Protein Data Bank code 2blt), the
Class D structure is the Oxa-10 -lactamase from Pseudomonas
aeruginosa (Protein Data Bank code 1e3u), and the PBP structure is
the D-Ala-D-Ala-peptidase/PBP from P. aeruginosa (Protein Data Bank code 1ceg).
|
|
Acylation and Deacylation of Tp47--
The interaction between
PBPs and
-lactams generally is described by the equation:
E + I
E.I
E-I
E + P, where E is the PBP enzyme,
I is the
-lactam, E.I is the Michaelis
intermediate, E-I is the covalent acyl-enzyme complex, and
P is the reaction product (i.e. cleaved, inactive
-lactam) (38). The formation of the enzymatically inactive
(covalent) acyl-enzyme complex (E-I) is known as the
acylation step. The covalent E-I complex results from the
nucleophilic attack of the carbonyl carbon atom of the
-lactam ring
by the hydroxyl group of the active site serine. The bactericidal
efficiency of any
-lactam ultimately depends on the stability of the
E-I complex. However, hydrolysis of the acyl-enzyme complex
and release of the inactive
-lactam (P) occurs by a
process known as deacylation; in the case of
-lactamases, deacylation is rapid. In former studies, Tp47 bound radiolabeled penicillin (7), and its binding to Dig-Amp subsequently was found to be
stimulated by zinc ions (13). In the current study, upon incubation of
purified Tp47 for 2 min with penicillin in the presence of zinc, two
major peaks of 47,703 Da (free Tp47) and 48,036 Da (penicillin-bound
Tp47) were detected by ESI-MS (not shown). The difference of 333 Da
between the two molecular masses corresponded with the mass of
penicillin (335 Da), indicating the formation of a covalent acyl-Tp47
complex bound predominantly in a 1:1 stoichiometry. Analogous results
were obtained using ampicillin, carbenicillin, cefuroxime, and
cephalosporin (not shown), indicating that recombinant Tp47 bound a
number of
-lactams. In the absence of zinc, after 2 min of
incubation, 5% of Tp47 became acylated, whereas, in the presence of
zinc, 33% of Tp47 was acylated over the same interval (Table
II), corroborating previous findings that
the PBP activity of Tp47 appears to be stimulated by zinc (13). In the
presence of zinc, acylation by penicillin was
time-dependent, with maximal binding observed at 6 min
(Table II). However, after 6 min, marked deacylation was evident,
implying that Tp47 exhibits some intrinsic
-lactamase activity.
View this table:
[in this window]
[in a new window]
|
Table II
Percent of Tp47 remaining acylated with penicillin at various times
Acylation reactions were carried out in either the presence (+) or
absence ( ) of 2 mM ZnCl2.
|
|
As shown in a previous study (13) and herein, zinc enhances the binding
of
-lactams to Tp47. This led to the initial idea that Tp47 was a
zinc-dependent PBP (13). Two lines of evidence now
challenge this view. First, we now show that rather than promoting acylation, zinc actually inhibits the deacylation of Tp47 (see below).
Second, an in vitro carboxypeptidase assay using the
synthetic depsipeptide substrate Sle (an analog of
D-Ala-D-Ala) initially suggested that Sle was
hydrolyzed by Tp47 in the presence of zinc, as indicated by an apparent
increase in UV absorption at 254 nm (13). However, subsequent
experiments have revealed that this apparent absorption increase is
due, at least in part, to scattering caused by Tp47 aggregates that
form in the presence of zinc (not shown). Hence, the initial contention
that Tp47 might be a zinc-dependent carboxypeptidase (13)
remains tenuous at this time.
Mass spectrometry has been employed for the identification of the
penicillin-binding site in Staphylococcus aureus PBP 2a (21). Using a similar strategy, liganded Tp47 was digested with trypsin, and peptide fragments were assessed by MALDI-TOF MS. Attempts
to identify a particular peptide fragment to which penicillin was bound
were unsuccessful, suggesting that the acylated product was unstable
during the procedure. One potential explanation for this was the
intrinsic
-lactamase activity inferred in Table II.
Kinetic Parameters for Tp47
-Lactamase Activities--
Certain
PBPs have intrinsic
-lactamase activity (30, 39). Kinetic analysis
of
-lactam hydrolysis was used to assess whether the deacylation of
Tp47 (Table II) was because of a similar intrinsic ability to hydrolyze
-lactams. The kinetic parameters of hydrolytic activities of Tp47
were determined for three
-lactams and are summarized in Table
III. Tp47 exhibited an unexpectedly high
level of
-lactam hydrolytic activity. Although the turnover rates
(kcat) for
-lactam hydrolysis by Tp47 were
10-20-fold lower than for typical
-lactamases (40), they are
substantially higher than the
-lactamase activity of E. coli PBP5, which has an unusually high
-lactamase activity
(kcat = 0.07 s
1) (39). On this
basis, it could be conjectured that Tp47 is a
-lactamase. However,
from a biological perspective, this notion is strongly inconsistent
with the exquisite sensitivity of T. pallidum to
-lactams, particularly when the extraordinary abundance of Tp47 in
T. pallidum is taken into account (41). Thus, the biological
relevance of the putative Tp47 in vitro
-lactamase activity remains suspect, as it may be of little or no consequence to
the biology of T. pallidum in vivo (i.e. during
human infection). Interestingly, a higher level of penicillin binding
to Tp47 was observed in the presence of zinc (Fig. 1 and Table II). As
noted earlier, zinc also induces the aggregation of Tp47 (not shown), which appears as a suppression of in vitro
-lactamase
activity. Taken together, it is tempting to speculate that the enhanced PBP activity of Tp47 has been observable, at least in part, by virtue
of the inhibitory action of zinc on the intrinsic
-lactamase activity of Tp47. Finally, the in vitro hydrolytic activity
of wild-type Tp47 was inhibited by tazobactam, an inhibitor of class A
-lactamases (42, 43), suggesting that competitive inhibition is
active site directed. The apparent Ki value for
hydrolysis of penicillin by wild-type Tp47 was 26.95 ± 0.35 nM.
View this table:
[in this window]
[in a new window]
|
Table III
Kinetic parameters for wild-type Tp47 hydrolytic activities using
ampicillin, penicillin G, or nitrocefin at pH 7.4 (37 °C)
|
|
Potential Active Site--
Catalytic centers of PBPs have a
conserved topology wherein three conserved motifs comprise the
catalytic center (10, 11). The sequence of Tp47 has three such
hypothetical signature motifs (13). However, mutations in the Ser of
the putative SVTK motif and Lys of the KTG motif did not abrogate the
PBP activity of Tp47 (Fig. 1). Furthermore, all three motifs of
classical PBPs initially thought to be present in Tp47 are found in
three different domains separated by distances greater than 30 Å (Fig.
2), supporting the contention that the three hypothetical motifs do not
comprise the active site for
-lactam binding in Tp47. We thus
conclude that Tp47 exhibits a unique mechanism for
-lactam binding.
Further inspection of the structure therefore was undertaken to
identify the active site. Emphasis was placed on searching for another reasonable PBP active site cleft, which might contain a Ser nucleophile spatially near another residue suitable for abstraction of a proton from the hydroxyl group of Ser (e.g. a positively charged
amino acid such as Lys). Such efforts were not successful.
The predominance of hydrophobic residues and the immunoglobulin fold of
domain D suggested that it might be utilized for protein-protein interaction(s) when in its native membrane setting within T. pallidum. In addition, the location, flexibility, and relative
disposition of domain D suggests that it might not be involved in PBP
and
-lactamase activities. In this regard, a domain D deletion
mutant of Tp47 (Tp47
D) retained wild-type levels of both activities (not shown). Thus, it is reasonable to conclude that domain D has no
catalytic role in the PBP activity of Tp47.
An analysis of the charge distribution on the surface of domains A-C
of the Tp47 monomer is shown in Fig. 6. A
positively charged cleft is found at the intersection of domains B and
C, close to the domain B
-hairpin formed by strands B
3 and B
4. This cleft might function as a binding site for the carboxylate of
D-Ala-D-Ala, and hence
-lactams. In the
crystal structure, this cleft is found near the noncrystallographic
2-fold axis of the dimer. A dextran sulfate polysaccharide with an
1
6 linkage was modeled into the positive difference density found
in this cleft. Approximately one-half of the electron density assigned to the polysaccharide is associated with each protein monomer, and the
hydrogen-bonding pattern between the protein and each sulfated dextrose
monosaccharide is similar. An attempt to model the polysaccharide
backbone of naturally occurring peptidoglycan (repeating
N-acetylmuramic acid (NAM)
1
4 linked to
N-acetylglucosamine) into this density was not successful.
An NAM monomer could be modeled into the density, but the
1
4
linkage of NAM-N-acetylglucosamine was inconsistent with the
local 2-fold symmetry of the cleft. If Tp47 utilizes this cleft for the
interaction of
1
4-linked peptidoglycan subunits, it appears that
steric constraints dictate that the protein be in the monomeric state,
as supported by our sedimentation equilibrium experiments. Whereas
small crystals of cTp47 normally can be grown in the absence of dextran
sulfate, crystallization with NAM or N-acetylglucosamine
monosaccharides in place of dextran sulfate did not yield cTp47
crystals.

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 6.
The cTp47 monomer has a positively charged
cleft. A surface representation of the electrostatic charge
distribution for the Tp47 monomer (domains A-C) is shown at the
left of the figure and is in the same orientation as in Fig.
2. The central figure was obtained via a rotation of 90°
about the horizontal axis of the monomer. For comparison, the charge
distribution for the active site cleft in the
D-Ala-D-Ala-peptidase/PBP (Protein Data Bank
code 1ceg) is shown at the right of the figure. The
displayed surface potential varies approximately from 10 to 10 kT
with acidic surfaces in red and basic in blue.
The electrostatic surface potential was calculated and rendered in the
program GRASP (52).
|
|
Further attempts to identify the active site of Tp47 by
co-crystallization and/or soaking of crystals with
-lactams were unsuccessful, probably because of the deacylation activity noted earlier. A 3.8-Å data set was obtained from a co-crystallization and
soak of cTp47 with the
-lactamase inhibitor tazobactam. The electron
density map revealed changes in the positively charged cleft that may
be because of a partial displacement of the dextran sulfate
polysaccharide by the tazobactam, but an unambiguous fit of the
inhibitor into this low resolution map was not possible.
Biological Significance and Implications--
Tp47 was first noted
in early molecular studies of T. pallidum, due largely to
its abundance and profound immunogenicity (41). It thus initially was
targeted for study as a potential syphilis serodiagnostic reagent (41,
44), and many newer generation serological tests for syphilis now
include Tp47 as a principal, if not sole, antigenic component (45, 46).
Tp47 initially also was thought to be an outer membrane protein (41).
However, a more extensive body of work, which has taken into account
the previously unrecognized fragility of the unusual T. pallidum outer membrane (1, 47), later supported that Tp47 likely
is a cytoplasmic membrane lipoprotein that, according to convention,
would protrude into the periplasmic space (47, 48). This finding was
more consistent with earlier studies that implicated it as a PBP (7, 13), inasmuch as PBPs reside at the cytoplasmic membrane (2). However,
the precise role of Tp47 in the biosynthesis of T. pallidum peptidoglycan remains unclear. Although corroborative data are lacking,
it is possible, implicated largely by its molecular mass, that Tp47 is
a DD-carboxypeptidase. If so, the marked abundance of Tp47 would imply
that it serves to limit the degree of cross-linking in the
peptidoglycan of T. pallidum, thereby promoting the rather remarkable, highly flexuous motility pattern of the spirochete (49).
Consistent with this view, other preliminary data have suggested that
the expression of full-length, lipidated Tp47 in E. coli
(13) reduces the degree of cross-linking in E. coli peptidoglycan.2
Despite both mutagenesis and x-ray crystallography data presented
herein, identification of the putative active site of Tp47 for
-lactam binding remains unresolved. The three-dimensional structure
of Tp47 has revealed a positively charged cleft that may bind
monosaccharides and/or possibly tazobactam, and that cleft might
function as an interaction site for the relevant carboxylate group of
D-Ala-D-Ala (and
-lactams), but more
conclusive evidence awaits further mutagenesis studies. Regardless, the
combined data provide compelling evidence that Tp47 represents a new
class of PBP. It also is not known to what extent this novel type of
PBP might be found in other bacterial pathogens, but it is anticipated that the burgeoning genomics field will eventually shed additional light on this. Finally, it is noteworthy that although not sharing homology with Tp47, a completely
-helical cysteine-rich protein B of
Helicobacter pylori recently was described as representing another new class of PBP (50). Although molecular modeling inferred that a site within the
-helical cysteine-rich protein B might bind
to NAM, the crystal structure also did not definitively reveal the
active site. Tp47 and the
-helical cysteine-rich protein B thus now
seem to represent two examples of PBPs that do not satisfy classical
PBP paradigms, the ramifications of which remain to be more fully explored.
 |
ACKNOWLEDGEMENTS |
We thank Taissia Popova and Martin Goldberg
for assistance with mutant constructions, Sandra Hill for excellent
technical assistance with crystal preparation and handling, Bikash
Pramanik for mass spectrometry, John Buynak for supplying tazobactam,
Joseph Albanesi for guidance with analytical ultracentrifugation,
Zbyszek Otwinowski for assistance in processing the laboratory source xenon-derivatized data set, and Andrzej Joachimiak and the staff of the
Structural Biology 19-ID beamline for expert aid in data collection.
 |
FOOTNOTES |
*
This work was supported by Grant AI-16692 from the NIAID,
National Institutes of Health, and by Grant I-0940 from the Robert A. Welch Foundation. Use of the Argonne National Laboratory Structural Biology Center beamline at the Advanced Photon Source was supported by
the United States Department of Energy, Office of Biological and
Environmental Research, under Contract W-31-109-ENG-38.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed: Dept. of
Microbiology, University of Texas Southwestern Medical Center, 6000 Harry Hines Blvd., Dallas, TX 75390. Tel.: 214-648-5900; Fax:
214-648-5905; E-mail: michael.norgard@utsouthwestern.edu.
Published, JBC Papers in Press, August 24, 2002, DOI 10.1074/jbc.M207402200
2
M. V. Norgard and M. S. Goldberg,
unpublished data.
 |
ABBREVIATIONS |
The abbreviations used are:
PBP, penicillin-binding proteins;
Dig-Amp, digoxigenin-labeled ampicillin;
MALDI-TOF, matrix-assisted laser desorption ionization time-of-flight;
ESI-MS, electrospray ionization-mass spectrometry;
NAM, N-acetylmuramic acid.
 |
REFERENCES |
| 1.
|
Radolf, J. D.
(1995)
Mol. Microbiol.
16,
1067-1073[Medline]
[Order article via Infotrieve]
|
| 2.
|
Ghuysen, J.-M.
(1988)
Rev. Infect. Dis.
10,
726-732[Medline]
[Order article via Infotrieve]
|
| 3.
|
Ghuysen, J.-M.
(1991)
Annu. Rev. Microbiol.
45,
37-67[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Massova, I.,
and Mobashery, S.
(1998)
Antimicrob. Agents Chemother.
42,
1-17[Free Full Text]
|
| 5.
|
Spratt, B. G.
(1975)
Proc. Natl. Acad. Sci. U. S. A.
72,
2999-3003[Abstract/Free Full Text]
|
| 6.
|
Nelson, D. E.,
and Young, K. D.
(2001)
J. Bacteriol.
183,
3055-3064[Abstract/Free Full Text]
|
| 7.
|
Radolf, J. D.,
Moomaw, C.,
Slaughter, C. A.,
and Norgard, M. V.
(1989)
Infect. Immun.
57,
1248-1254[Abstract/Free Full Text]
|
| 8.
|
Cunningham, T. M.,
Miller, J. N.,
and Lovett, M. A.
(1987)
J. Bacteriol.
169,
5298-5300[Abstract/Free Full Text]
|
| 9.
|
Fraser, C. M.,
Norris, S. J.,
Weinstock, G. M.,
White, O.,
Sutton, G. G.,
Dodson, R.,
Gwinn, M.,
Hickey, E. K.,
Clayton, R.,
Ketchum, K. A.,
Sodergren, E.,
Hardham, J. M.,
McLeod, M. P.,
Salzberg, S.,
Peterson, J.,
Khalak, H.,
Richardson, D.,
Howell, J. K.,
Chidambaram, M.,
Utterback, T.,
McDonald, L.,
Artiach, P.,
Bowman, C.,
Cotton, M. D.,
Fujii, C.,
Garland, S.,
Hatch, B.,
Horst, K.,
Roberts, K.,
Sandusky, M.,
Weidman, J.,
Smith, H. O.,
and Venter, J. C.
(1998)
Science
281,
375-388[Abstract/Free Full Text]
|
| 10.
|
Spratt, B. G.,
and Cromie, K. D.
(1988)
Rev. Infect. Dis.
10,
699-711[Medline]
[Order article via Infotrieve]
|
| 11.
|
Goffin, C.,
and Ghuysen, J.-M.
(1998)
Microbiol. Mol. Biol. Rev.
62,
1079-1093[Abstract/Free Full Text]
|
| 12.
|
Kelly, J. A.,
Kuzin, A. P.,
Charlier, P.,
and Fonze, E.
(1998)
Cell. Mol. Life Sci.
54,
353-358[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Weigel, L. M.,
Radolf, J. D.,
and Norgard, M. V.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
11611-11615[Abstract/Free Full Text]
|
| 14.
|
Weigel, L. M.
(1994)
Structure-function Relationships of the 47-kilodalton Major Membrane Lipoprotein of Treponema pallidumPh.D. Dissertation
, University of Texas Southwestern Graduate School of Biomedical Sciences
|
| 15.
|
Hayashi, S.,
Hara, H.,
Suzuki, H.,
and Hirota, Y.
(1988)
J. Bacteriol.
170,
5392-5395[Abstract/Free Full Text]
|
| 16.
|
Weigel, L. M.,
Brandt, M. E.,
and Norgard, M. V.
(1992)
Infect. Immun.
60,
1568-1576[Abstract/Free Full Text]
|
| 17.
|
Norgard, M. V.,
and Miller, J. N.
(1983)
Infect. Immun.
42,
435-445[Abstract/Free Full Text]
|
| 18.
|
Chamberlain, N. R.,
Brandt, M. E.,
Erwin, A. L.,
Radolf, J. D.,
and Norgard, M. V.
(1989)
Infect. Immun.
57,
2872-2877[Abstract/Free Full Text]
|
| 19.
|
Gill, S. C.,
and von Hippel, P. H.
(1989)
Anal. Biochem.
182,
319-326[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Weigel, L. M.,
Belisle, J. T.,
Radolf, J. D.,
and Norgard, M. V.
(1994)
Antimicrob. Agents Chemother.
38,
330-336[Abstract/Free Full Text]
|
| 21.
|
Sun, Y.,
Bauer, M. D.,
and Lu, W.
(1998)
J. Mass Spectrom.
33,
1009-1016[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Lu, W.-P.,
Sun, Y.,
Bauer, M. D.,
Paule, S.,
Koenigs, P. M.,
and Kraft, W. G.
(1999)
Biochemistry
38,
6537-6546[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
van Oers, N. S. C.,
Tohlen, B.,
Malissen, B.,
Moomaw, C. R.,
Afendis, S.,
and Slaughter, C. A.
(2000)
Nat. Immunol.
1,
322-328[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
McPherson, A.
(1990)
Eur. J. Biochem.
189,
1-23[Medline]
[Order article via Infotrieve]
|
| 25.
|
Otwinowski, Z.,
and Minor, W.
(1997)
Methods Enzymol.
276,
307-326
|
| 26.
|
Brunger, A. T.,
Adams, P. D.,
Clore, G. M.,
DeLano, W. L.,
Gros, P.,
Grosse-Kunstleve, R. W.,
Jiang, J. S.,
Kuszewski, J.,
Nilges, M.,
Pannu, N. S.,
Read, R. J.,
Rice, L. M.,
Simonson, T.,
and Warren, G. L.
(1998)
Acta Crystallogr. Sect. D
54,
905-921[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Perrakis, A.,
Morris, R. J.,
and Lamzin, V. S.
(1996)
Nat. Struct. Biol.
6,
458-463
|
| 28.
|
Jones, T. A.,
Zou, J. Y.,
Cowan, S. W.,
and Kjeldgaard, M.
(1991)
Acta Crystallogr. Sect. A
47,
110-119
|
| 29.
|
Hayashi, S.,
and Wu, H. C.
(1990)
J. Bioenerg. Biomembr.
22,
451-471[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
van der Linden, M. P. G.,
de Haan, L.,
Dideberg, O.,
and Keck, W.
(1994)
Biochem. J.
303,
357-362
|
| 31.
|
Hadonou, A. M.,
Wilkin, J. M.,
Varetto, L.,
Joris, B.,
Lamotte-Brasseur, J.,
Klein, D.,
Duez, C.,
Ghuysen, J.-M.,
and Frere, J.-M.
(1992)
Eur. J. Biochem.
207,
97-102[Medline]
[Order article via Infotrieve]
|
| 32.
|
Malhotra, K. T.,
and Nicholas, R. A.
(1992)
J. Biol. Chem.
267,
11386-11391[Abstract/Free Full Text]
|
| 33.
|
Holm, L.,
and Sander, C.
(1993)
J. Mol. Biol.
233,
123-138[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Turk, B.,
Turk, V.,
and Turk, D.
(1997)
Biol. Chem.
378,
141-150[Medline]
[Order article via Infotrieve]
|
| 35.
|
Ponsting, H.,
Henrick, K.,
and Thornton, J. M.
(2000)
Proteins
41,
47-57[CrossRef][Medline]
[Order article via Infotrieve]
|
| 36.
|
Kerfeld, C. A.,
Salmeen, A. E.,
and Yeates, T. O.
(1998)
Biochemistry
37,
13911-13917[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Janin, J.,
and Rodier, F.
(1997)
Proteins
23,
580-587[CrossRef]
|
| 38.
|
Matagne, A.,
Lamotte-Brasseur, J.,
and Frere, J.-M.
(1998)
Biochem. J.
330,
581-598
|
| 39.
|
Davies, C.,
White, S. W.,
and Nicholas, R. A.
(2001)
J. Biol. Chem.
276,
616-623[Abstract/Free Full Text]
|
| 40.
|
Kelly, J. A.,
Dideberg, O.,
Charlier, P.,
Wery, J. P.,
Libert, M.,
Moews, P. C.,
Knox, J. R.,
Duez, C.,
Fraipont, C.,
Joris, B.,
Dusart, J.,
Frere, J. M.,
and Ghuysen, J. M.
(1986)
Science
231,
1429-1431[Abstract/Free |